Received Apr 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | EWO162 | IM / RA |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | EWO168 | IM |
I received the Pfizer COVID-19 vaccine in my right arm on May 15,2021 and the 2nd vaccine on June 10, 2021. in July of 2021 I developed a mass in my right breast that was later diagnosed as a hamartoma wild type. In February of 2023 DCIs was visible on a mammogram, that was not present six months prior. In September of 2023 I had swelling of my right breast and bloody discharge from nipple. In December 2023 I was diagnosed with ductal carcinoma in situ (DCIS), high-grade, also in my right breast. There is no family history of breast cancer, and I had no known prior breast abnormalities before this timeframe. I am reporting this due to the temporal relationship between the vaccine and the development of two separate breast-related conditions on the same side as the injection site. I understand this does not prove causation, but I believe it should be documented for safety monitoring purposes. I had a single mastectomy in February of 2024 with clean margins' and no lymph node involvement.
no
no
Adderall, sertraline, multivitamin, omega 3, spironolactone, collagen
no
I had a surgery on 11/28/23 to remove the hamartoma and the milk duct causing the bloody discharge. The pathology report diagnosed hamartoma and DCIS.